HLA-B27 Positivity Did Not Influence CLL, SLL Outcomes
Further studies needed to look at relevance outside of the transplant-eligible population.
All articles by Leah Lawrence
CDK4/6 Inhibitors Should Be Standard First-Line Treatment for Metastatic HR+ Breast Cancer, Concludes Expert
Emerging overall survival data show a benefit of this type of drug across a variety of patient subgroups.
Real-World Data Useful to Quantify Benefit of New Cancer Therapies
Data could support regulatory, payer decision making.
Experts Recommend Cytologic Test Every 3 Years, High-Risk HPV Test Every 5 Years
A new study challenges the recommended use of cotesting for cervical cancer screening.
Unrelated Donor Transplant Yields Better Results than Cord Blood in R/R Acute Myeloid Leukemia
Cord blood transplant resulted in poorer nonrelapse mortality and leukemia-free survival.
Rituximab Biosimilar CT-P10 Equivalent as Monotherapy for Follicular Lymphoma
US FDA recently approved rituximab biosimilar as monotherapy and in combination with chemotherapy.
Opioid Epidemic Response May Be Limiting Cancer-Related Pain Management
A report on current legislation and practice trends regarding opioids and how they are affecting cancer patients’ ability to manage their pain.
Breast Cancer Follow-Up Care Recommendations: Considerations for a Growing Survivorship Population
Women with a history of breast cancer face a wide variety of challenges as they transition from the role of “patient” to “survivor”.
Next post in Breast Cancer
